Klivira
Request demo

Streamlining Urology Availity Integration for Prior Authorization

Klivira streamlines urology Availity integration to accelerate prior authorization workflows for high-volume treatments and procedures, ensuring timely patient care.

Revenue cycle directors and prior authorization coordinators in urology face complex PA requirements for specialty drugs, advanced imaging, and surgical interventions. Manual processing through multi-payer portals like Availity Essentials can consume significant staff time and delay patient access to critical care. Automating this integration is critical for operational efficiency and patient outcomes.

The Critical Role of Urology Availity Integration

Urology practices frequently leverage Availity Essentials as a primary multi-payer clearinghouse to submit prior authorization requests across numerous commercial payers. Efficient urology Availity integration is essential for managing the high volume of PAs for conditions like prostate cancer, benign prostatic hyperplasia (BPH), and overactive bladder (OAB), ensuring timely access to critical treatments and reducing administrative burden.

High-Volume Urology PA Categories Managed via Availity

  • Prostate cancer therapeutics (e.g., Xtandi, Pluvicto) and PSMA imaging (e.g., Pylarify).
  • BPH treatments, including minimally invasive procedures (UroLift, Rezum, Aquablation) and traditional surgical interventions.
  • Overactive bladder medications (e.g., Myrbetriq, onabotulinumtoxinA/Botox injections) and sacral neuromodulation (InterStim).
  • Robotic urologic surgery, such as prostatectomy, partial/radical nephrectomy, and cystectomy.
  • Select erectile dysfunction treatments and stone disease management procedures (e.g., ESWL, ureteroscopy).

Streamlining Documentation for Urology PAs via Availity

Successful urology prior authorizations submitted through Availity depend on robust clinical documentation. Payers often require specific data points aligning with AUA Clinical Practice Guidelines and NCCN for urologic oncology, such as Gleason score, PSA, IPSS, and prior treatment history, to establish medical necessity and prevent denials.

Key Documentation Elements for Availity Submissions

  • Gleason score, stage, PSA, and prior treatments for prostate cancer, often per NCCN-compendium-supported indications.
  • International Prostate Symptom Score (IPSS), prostate size, and duration of failed medical therapy trial for BPH treatments.
  • Biochemical recurrence documentation (PSA rise post-treatment) or initial staging indication per NCCN for PSMA imaging.
  • Documentation of failed conservative therapy and trial-phase results for neuromodulation (InterStim).
  • Symptom severity and duration of failed medical therapy for UroLift/Rezum/Aquablation procedures.

Klivira's Automated Approach to Urology Availity Workflows

Klivira's platform automates the data extraction and submission process for urology prior authorizations, directly integrating with your EMR using standards like SMART on FHIR and connecting to Availity. This ensures that requests for high-cost specialty drugs, advanced imaging, and complex procedures are submitted accurately and promptly, minimizing manual data entry and accelerating the approval cycle.

Mitigating Common Denial Reasons in Urology Availity Submissions

Our system helps urology practices preempt common denial reasons encountered when submitting to Availity, such as step therapy for ED or OAB medications, medical-necessity gaps for advanced prostate cancer drugs, or insufficient conservative-therapy duration for BPH treatments. Klivira's intelligent workflows also account for NCD/LCD constraints applicable to studies like PSMA imaging, ensuring compliance and improving first-pass approval rates.

Frequently asked questions

How does Klivira handle specific urology PA requirements through Availity?

Klivira leverages AUA/NCCN-guideline-aware policy logic to automate documentation for common urology PAs, such as prostate cancer regimens, BPH conservative-therapy trials, and OAB benefit-coverage routing, ensuring accurate submissions via Availity. This reduces manual effort and improves compliance with payer rules.

Can Klivira integrate with our EMR to pull urology patient data for Availity submissions?

Yes, Klivira integrates with major EMRs using standards like SMART on FHIR to automatically extract relevant clinical data (e.g., PSA, Gleason score, IPSS) for populating Availity prior authorization forms. This eliminates manual data entry, reduces errors, and speeds up the submission process.

What types of urology procedures and drugs benefit most from Availity integration automation?

High-volume and high-cost urology PAs, including prostate cancer therapeutics, BPH procedures (UroLift, Aquablation), OAB medications, and PSMA imaging, benefit significantly from automated Availity integration due to their complex documentation needs and the urgency often associated with treatment initiation.

How does Klivira help reduce denials for urology PAs submitted through Availity?

Klivira's platform pre-validates submissions against payer-specific rules and common denial reasons (e.g., step therapy, medical-necessity gaps, insufficient conservative therapy duration). This proactive approach ensures that urology PAs submitted to Availity are complete and compliant, improving approval rates and reducing resubmission efforts.

Does Klivira support NCD/LCD considerations for urology imaging like PSMA PET?

Yes, Klivira's system incorporates policy logic that considers NCD/LCD constraints relevant to urology imaging, such as PSMA PET. This helps ensure that documentation for these advanced imaging studies aligns with payer requirements when submitted via Availity, minimizing the risk of denials related to coverage criteria.

Related coverage

Other urology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo